Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial.

HY, Kim; PN, Hsu; M, Barba; W, Sulaiman; D, Robertson; B, Vlahos; R, Khandker; H, Nab; B, Freundlich; A, Koenig

doi:10.1111/j.1756-185x.2011.01680.x

Public

Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial.

Shared by NobleBlocks on Oct 28, 2011 • 12:00 AM UTC

Authors:

Kim HY

Hsu PN

Barba M

Abstract

<h4>Aim</h4>Rheumatoid arthritis (RA) is an important rheumatologic disease in Asia-Pacific countries, as in other parts of the world. However, limited information is available regarding RA therapy in this region. The Asia-Pacific Study in Patients to be Treated With Etanercept or an Alternative Lis...

Discussions